BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9755663)

  • 1. Peritoneal washing cytology of ovarian tumors of low malignant potential: correlation with surface ovarian involvement and peritoneal implants.
    Cheng L; Wolf NG; Rose PG; Rodriguez M; Abdul-Karim FW
    Acta Cytol; 1998; 42(5):1091-4. PubMed ID: 9755663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytohistologic correlation in malignant peritoneal washings. Analysis of 75 malignant fluids.
    Mulvany N
    Acta Cytol; 1996; 40(6):1231-9. PubMed ID: 8960034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome.
    Sneige N; Thomison JB; Malpica A; Gong Y; Ensor J; Silva EG
    Cancer Cytopathol; 2012 Aug; 120(4):238-44. PubMed ID: 22826172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histologic subtype of ovarian tumors affects the detection rate by pelvic washings.
    Fadare O; Mariappan MR; Wang S; Hileeto D; McAlpine J; Rimm DL
    Cancer; 2004 Jun; 102(3):150-6. PubMed ID: 15211473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of peritoneal washing cytology in ovarian malignancies: correlation with histopathological parameters.
    Naz S; Hashmi AA; Ali R; Faridi N; Hussian SD; Edhi MM; Khan M
    World J Surg Oncol; 2015 Nov; 13():315. PubMed ID: 26556439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of peritoneal washing cytology in staging and prognosis of ovarian and fallopian tube neoplasms: a 10-year retrospective analysis.
    Davidson W; Madan R; O'Neil M; Tawfik OW; Fan F
    Ann Diagn Pathol; 2016 Jun; 22():54-7. PubMed ID: 27180061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneal washing cytology in gynecologic cancers: long-term follow-up of 355 patients.
    Zuna RE; Behrens A
    J Natl Cancer Inst; 1996 Jul; 88(14):980-7. PubMed ID: 8667429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular genetic evidence of an independent origin of serous low malignant potential implants and lymph node inclusions.
    Emerson RE; Wang M; Liu F; Lawrence WD; Abdul-Karim FW; Cheng L
    Int J Gynecol Pathol; 2007 Oct; 26(4):387-94. PubMed ID: 17885488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Image analysis of cellular DNA content in peritoneal fluid of patients with ovarian tumors of low malignant potential and invasive epithelial ovarian cancer.
    Guidozzi F; Szumel RC; Ball JH; Johnston DA; Katz RL; Kidd L
    Gynecol Oncol; 1996 May; 61(2):204-9. PubMed ID: 8626133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian papillary serous tumors of low malignant potential (serous borderline tumors). A long-term follow-up study, including patients with microinvasion, lymph node metastasis, and transformation to invasive serous carcinoma.
    Kennedy AW; Hart WR
    Cancer; 1996 Jul; 78(2):278-86. PubMed ID: 8674004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
    McKenney JK; Soslow RA; Longacre TA
    Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian serous tumors of low malignant potential (serous borderline tumors). The relationship of exophytic surface tumor to peritoneal "implants".
    Segal GH; Hart WR
    Am J Surg Pathol; 1992 Jun; 16(6):577-83. PubMed ID: 1599036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significance of intraoperatively obtained peritoneal cytology in malignant ovarian tumors].
    Göppinger A; Hilgarth M; Pfleiderer A; Hillemanns HG
    Geburtshilfe Frauenheilkd; 1986 Nov; 46(11):808-10. PubMed ID: 3803875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current concepts in management of epithelial ovarian tumors of low malignant potential.
    Elchalal U; Dgani R; Piura B; Anteby SO; Zalel Y; Czernobilsky B; Schenker JG
    Obstet Gynecol Surv; 1995 Jan; 50(1):62-70. PubMed ID: 7891967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peritoneal washing cytology at second-look laparotomy in cisplatin-treated ovarian cancer patients.
    Kudo R; Takashina T; Ito E; Mizuuchi H; Sagae S; Moriwaka O; Tamagawa A
    Acta Cytol; 1990; 34(4):545-8. PubMed ID: 2375223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    McKenney JK; Balzer BL; Longacre TA
    Am J Surg Pathol; 2006 Oct; 30(10):1209-21. PubMed ID: 17001150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The value of peritoneal cytology in the staging of ovarian cancer].
    Emerich J; Konefka T; Dudziak M; Sobol A
    Ginekol Pol; 1997 Feb; 68(2):74-7. PubMed ID: 9499000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological Parameters Associated With Peritoneal Involvement in Epithelial Ovarian Tumors.
    Hashmi AA; Rashid K; Asif MG; Dowlah TU; Ali AH; Malik UA; Ali SM; Ali SJ; Zia S; Irfan M
    Cureus; 2023 Mar; 15(3):e36666. PubMed ID: 37102035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peritoneal washing cytology in cervical carcinoma. Analysis of 109 patients.
    Zuna RE; Hansen K; Mann W
    Acta Cytol; 1990; 34(5):645-51. PubMed ID: 2220243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peritoneal cytology as an indicator of disease in patients with residual ovarian carcinoma.
    Rubin SC; Dulaney ED; Markman M; Hoskins WJ; Saigo PE; Lewis JL
    Obstet Gynecol; 1988 Jun; 71(6 Pt 1):851-3. PubMed ID: 3285264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.